Provell Pharmaceuticals: Funding, Investors & Team (Sep 2026)
Provell Pharmaceuticals is a medical organization that has some expertise in the showcasing and dissemination of drug items. Through its worldwide associations, it brings advancement, without compromising quality. It plans to work on understanding results by offering constant drugs in unmistakable bundling to assist patients with accomplishing better adherence and in general wellbeing. It was established in 2005 and is settled in Honey Brook, Pennsylvania.
Provell Pharmaceuticals has raised $4.0M across 2 funding rounds on record, the most recent an undisclosed round of $2.0M announced in Mar 2023.
That round is below the $4.8M median round size for Health Care companies tracked on FundedIQ over the last two years.
Provell Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Mar 2023.
Provell Pharmaceuticals Funding Rounds
Provell Pharmaceuticals raised $2.0M in an undisclosed round announced in Jul 2022.
8 months later, an undisclosed round of $2.0M was announced in Mar 2023.
Provell Pharmaceuticals Founders and Leadership Team
Contact details for the Provell Pharmaceuticals team: 2 of 2 have an email address on file.
Start 14-day free trial →Provell Pharmaceuticals Funding Compared to Other Health Care Startups
Provell Pharmaceuticals' latest round of $2.0M is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Provell Pharmaceuticals in Health Care and Honey Brook
Companies Similar to Provell Pharmaceuticals
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
Thyme Care is an oncology solution that integrates patients and providers, working with health plans to…
https://metriport.com
There are too many reasons why Healthcare is unaffordable in the U.S, but one of the largest is waste. Up to…
Serif Health provides healthcare price intelligence and contract management solution.
Switchboard Health provides virtual care solutions to payers, health systems, employers, and at-risk…
Astek Diagnostics has designed a system that helps doctors choose the right antibiotics for patients…
TECLens is developing a crosslinking technology that can effectively address vision problems in both healthy…
Gradient Health collaborates with medical data providers worldwide to assemble diseases and conditions for AI…
Healthcare Shares operates as a crowdfunding portal for the transformative medical innovations of the future.
Kalivir designs safe and potent oncolytic product candidates across multiple tumor types. Kalivir’s…
Happy Health is a mission-driven technology company committed to transforming mental health awareness through…
Provell Pharmaceuticals Funding FAQs
What does Provell Pharmaceuticals do?
Provell Pharmaceuticals is a medical organization that has some expertise in the showcasing and dissemination of drug items. Through its worldwide associations, it brings advancement, without compromising quality. It plans to work on understanding results by offering constant drugs in unmistakable bundling to assist patients with accomplishing better adherence and in general wellbeing. It was established in 2005 and is settled in Honey Brook, Pennsylvania.
How much funding has Provell Pharmaceuticals raised?
Provell Pharmaceuticals has raised $4.0M across 2 rounds on record. The most recent is an undisclosed round of $2.0M announced in Mar 2023.
When did Provell Pharmaceuticals last raise funding?
Provell Pharmaceuticals' most recent funding round on record is an undisclosed round of $2.0M, announced in Mar 2023.
Who founded Provell Pharmaceuticals?
FundedIQ lists Kurt Kalm (Founder) at Provell Pharmaceuticals.
Who is the CEO of Provell Pharmaceuticals?
Jim Small is listed as CEO at Provell Pharmaceuticals.
Where is Provell Pharmaceuticals headquartered?
Provell Pharmaceuticals is based in Honey Brook, Pennsylvania, United States.
How many employees does Provell Pharmaceuticals have?
Provell Pharmaceuticals is in the 1-10 employee band.
How does Provell Pharmaceuticals' funding compare to other Health Care startups?
Provell Pharmaceuticals' latest round of $2.0M is below the $4.8M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Provell Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Provell Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.